InsiderTrades.com logo
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

ELYM Insider Trading

Insider Ownership Percentage: 4.70%
Insider Buying (Last 12 Months): $49,952,816.64
Insider Selling (Last 12 Months): $2,146,236.31

Eliem Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Eliem Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eliem Therapeutics Share Price & Price History

Current Price: $1.95
Price Change: +0.30 (1.20%)
As of 12/20/2024 01:00 AM ET

This chart shows the closing price history over time for ELYM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
From Behind the Markets   |   Ad
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Click here for the ticker >>>

Eliem Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/20/2024Emily PimblettCAOSell1,191$8.18$9,742.387,564View SEC Filing Icon  
7/22/2024Valerie MorissetEVPSell69,005$8.03$554,110.1531,317View SEC Filing Icon  
7/19/2024Valerie MorissetEVPSell60,201$7.21$434,049.21100,322View SEC Filing Icon  
7/17/2024Valerie MorissetEVPSell3,207$6.91$22,160.37199,099View SEC Filing Icon  
7/15/2024Valerie MorissetEVPSell42,377$7.01$297,062.77252,306View SEC Filing Icon  
7/11/2024Valerie MorissetEVPSell50,000$7.11$355,500.00344,683View SEC Filing Icon  
7/9/2024Valerie MorissetEVPSell5,931$6.66$39,500.46444,683View SEC Filing Icon  
7/5/2024Valerie MorissetEVPSell12,342$7.06$87,134.52450,614View SEC Filing Icon  
7/3/2024Valerie MorissetEVPSell50,000$6.76$338,000.00462,956View SEC Filing Icon  
6/27/2024Ra Capital Management, L.P.DirectorBuy13,008,546$3.84$49,952,816.6423,521,757View SEC Filing Icon  
6/20/2024Emily PimblettCAOSell1,245$7.21$8,976.453,755View SEC Filing Icon  
See Full Table
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
From Behind the Markets   |   Ad
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Eliem Therapeutics (NASDAQ:ELYM)

69.76% of Eliem Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELYM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Eliem Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC38,859$0.20M0.0%+1,428.1%0.131%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC38,859$0.20M0.0%+1,428.1%0.131%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC10,907$56K0.0%N/A0.037%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.181,970$0.93M0.1%-15.4%0.612%Search for SEC Filing on Google Icon
11/15/2024State Street Corp315,036$1.60M0.0%+433.9%1.059%Search for SEC Filing on Google Icon
11/15/2024Samsara BioCapital LLC2,609,114$13.28M2.6%-20.0%8.770%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.590,946$3.01M0.0%N/A1.986%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC278,775$1.42M0.2%N/A0.937%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC175,100$0.89M0.1%+75.1%0.589%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC3,606,495$18.30M0.0%+10.8%12.122%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC1,229,292$6.26M3.3%+145.9%4.132%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC17,769$90K0.0%N/A0.060%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC248,168$1.26M0.4%N/A0.834%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP48,169$0.25M0.1%N/A0.162%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company49,524$0.25M0.0%N/A0.166%Search for SEC Filing on Google Icon
11/12/2024Valence8 US LP12,045$61K0.0%N/A0.040%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.70,093$0.36M0.0%+309.2%0.236%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC58,411$0.30M0.0%N/A0.196%Search for SEC Filing on Google Icon
10/29/2024Chicago Partners Investment Group LLC16,966$81K0.0%N/A0.057%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC11,715$60K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC696,057$4.95M0.0%-14.2%2.340%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC1,670,661$11.88M1.4%N/A5.615%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC500,000$3.56M2.1%N/A1.681%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC37,000$0.26M0.0%+248.5%0.124%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP12,560$89K0.0%N/A0.042%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers8,233$59K0.0%N/A0.028%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp18,845$0.13M0.0%N/A0.063%Search for SEC Filing on Google Icon
4/23/2024BML Capital Management LLC2,193,742$6.01M4.0%+0.6%7.914%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC2,180,000$5.89M4.4%+12.5%7.907%Search for SEC Filing on Google Icon
1/26/2024Cerity Partners LLC13,821$37K0.0%N/A0.050%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC121,110$0.32M0.1%-75.5%0.447%Search for SEC Filing on Google Icon
10/23/2023BML Capital Management LLC1,938,263$5.10M4.7%+22.4%7.155%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC494,089$1.38M0.4%+1.7%1.830%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC810,593$2.27M0.0%+20.3%3.003%Search for SEC Filing on Google Icon
7/24/2023BML Capital Management LLC1,583,170$4.43M4.0%-4.5%5.866%Search for SEC Filing on Google Icon
4/14/2023BML Capital Management LLC1,658,170$4.81M4.2%-9.1%6.148%Search for SEC Filing on Google Icon
2/14/2023Driehaus Capital Management LLC551,942$2.03M0.0%+58.3%2.077%Search for SEC Filing on Google Icon
2/13/2023BML Capital Management LLC1,825,134$6.70M6.4%N/A6.869%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can25,244$93K0.0%N/A0.095%Search for SEC Filing on Google Icon
11/8/2022Atom Investors LP67,074$0.22M0.1%+154.9%0.252%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC402,088$1.30M0.4%-43.6%1.513%Search for SEC Filing on Google Icon
8/16/2022Parkwood LLC67,202$67K0.2%+63.4%0.253%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC713,009$2.15M0.7%+707.7%2.684%Search for SEC Filing on Google Icon
5/12/2022Monashee Investment Management LLC227,201$1.91M0.6%-24.3%0.855%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd15,874$0.13M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP373,368$3.91M0.1%-3.6%1.406%Search for SEC Filing on Google Icon
2/15/2022Samlyn Capital LLC1,703,546$17.82M0.2%+1.3%6.417%Search for SEC Filing on Google Icon
2/11/2022Parkwood LLC30,609$0.32M0.1%N/A0.115%Search for SEC Filing on Google Icon
2/7/2022Monashee Investment Management LLC300,000$3.14M0.8%-1.7%1.130%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund3,359$35K0.0%N/A0.013%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC2,880$30K0.0%N/A0.011%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP100,000$1.80M0.0%N/A0.377%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al287,294$5.17M0.0%N/A1.082%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.13,150,849$236.45M3.3%N/A49.536%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$1.35M0.0%N/A0.283%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC76,904$1.38M0.0%N/A0.290%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.165,952$2.98M0.0%N/A0.625%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.332,126$5.97M0.0%N/A1.251%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC305,233$5.49M1.0%N/A1.150%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG4,063$73K0.0%N/A0.015%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Eliem Therapeutics logo
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Read More on Eliem Therapeutics

Today's Range

Now: $1.95
Low: $1.86
High: $2.07

50 Day Range

MA: $3.61
Low: $1.95
High: $5.44

52 Week Range

Now: $1.95
Low: $2.35
High: $11.55

Volume

1,467,291 shs

Average Volume

486,688 shs

Market Capitalization

$58.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Eliem Therapeutics?

Eliem Therapeutics' top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. Valerie Morisset (EVP)
  3. Emily Pimblett (CAO)
Learn More about top insider investors at Eliem Therapeutics.

Who are the major institutional investors of Eliem Therapeutics?

Eliem Therapeutics' top institutional shareholders include:
  1. Janus Henderson Group PLC — 12.12%
  2. Samsara BioCapital LLC — 8.77%
  3. Ally Bridge Group NY LLC — 4.13%
  4. Point72 Asset Management L.P. — 1.99%
  5. State Street Corp — 1.06%
  6. Parkman Healthcare Partners LLC — 0.94%
Learn More about top institutional investors of Eliem Therapeutics stock.

Which institutional investors are selling Eliem Therapeutics stock?

During the last quarter, ELYM stock was sold by these institutional investors:
  1. Samsara BioCapital LLC
  2. Sphera Funds Management LTD.
In the last year, company insiders that have sold Eliem Therapeutics company stock include:
  1. Ra Capital Management, LP (Director)
  2. Valerie Morisset (EVP)
Learn More investors selling Eliem Therapeutics stock.

Which institutional investors are buying Eliem Therapeutics stock?

In the last quarter, ELYM stock was purchased by institutional investors including:
  1. Ally Bridge Group NY LLC
  2. Point72 Asset Management L.P.
  3. Janus Henderson Group PLC
  4. Parkman Healthcare Partners LLC
  5. State Street Corp
  6. Great Point Partners LLC
  7. Ikarian Capital LLC
  8. Segall Bryant & Hamill LLC
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.